NL-OMON20882尚未招募不适用
Clonidine Augmentation Therapy in Schizophrenia
niversitair Medisch Centrum Utrecht0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. A DSM-IV-R diagnosis of: 295.x (schizophrenia, schizophreniform disorder, or schizoaffective disorder)
- •2. No or only partial response to clozapine as defined by a total PANSS score of at least 80.
排除标准
- •1. Presence of any of the contra-indications of clonidine as reported in the Summary of Product Characteristics (SPC).
- •2. Supine systolic blood pressure (SSBP) < 85 mm HG
研究者
相似试验
已完成
不适用
Clonidine Augmentation Treatment in SchizophreniaPsychotic disorder10039628schizophreniaNL-OMON44666niversitair Medisch Centrum Utrecht75
进行中（未招募）
不适用
Clonidine added to the current treatment of therapy resistant schizophreniaSchizophrenia, schizophreniform disorder, schizoaffective disorderEUCTR2014-003008-53-NLniversity Medical Center Utrecht75
终止
3 期
Augmentation of antipsychotic medication with anticonvulsant in the management of treatment resistant schizophreniaMental and Behavioural DisordersSchizophreniaISRCTN77257074King's College London371
已完成
4 期
Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant SchizophreniaSchizophrenic DisordersPsychotic DisorderSchizophreniaNCT01279213Universidad Nacional de Rosario70
尚未招募
不适用
Investigating the effectiveness of adding Clonidine and Gabapentin to Buprenorphine during detoxification of children and adolescents with Opioid Use DisordersIRCT20110411006168N4Kerman University of Medical Sciences40